3D InSightâ„¢ | 3D In Vitro Liver Toxicology

Your proven end-to-end 3D in vitro liver safety solution portfolio - from reliable hazard identification to insights into translational and clinical toxicology

Industry-ready 3D In Vitro Liver Toxicology Solutions

InSphero’s 3D InSight™ Liver Safety solutions deliver precise and predictive 3D in vitro liver models for liver toxicity assessment since 2013. Our 3D in vitro liver toxicology technology accurately models the intricate architecture and functions of the human liver with a physiologically relevant microenvironment to enable better assessments of drug metabolism and toxicological responses. By incorporating our 3D InSight™ Liver Safety solutions into your workflow, you will gain valuable insights into:

3D InSight™  Liver Microtissues, our proprietary spherical liver models, are composed of primary hepatocytes and non-parenchymal liver cells and are available in Akura™ 96 & 384 spheroid microplates.

Variants of the 3D InSightâ„¢ liver microtissues are available for both human and preclinical species. These models allow for the measurement of a wide range of hepatic biomarkers, including but not limited to:

  • ATP
  • ALT leakage
  • Cytochrome P450 activity
  • Albumin secretion
  • Cytokine secretion
  • Bile acid secretion
  • Glycogen,
  • Triglycerides, as well as data from transcriptomics, proteomics, and lipidomics

The physiological relevance of the 3D InSight™ liver microtissues, broad range of specialized in vitro assays available, combined with the scalability, robustness, and reproducibility of InSphero’s technology makes of InSphero’s 3D in vitro liver toxicology solutions an industry-ready solution for both the screening of large set of compounds early in the drug development process and the in depth and complex evaluation of a small number of selected drug candidates before first in human studies.  

 

Discover the application of InSphero's Liver Safety Solutions in peer-reviewed papers:

Proctor, W.R., Foster, A.J., Vogt, J. et al. Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury. Arch Toxicol 91, 2849–2863 (2017). 

Messner, S., Agarkova, I., Moritz, W. et al. Multi-cell type human liver microtissues for hepatotoxicity testing. Arch Toxicol 87, 209–213 (2013)

 

Why 3D In Vitro Liver Toxicology with InSphero?

InSphero’s 3D In Vitro Liver Safety Platform has been developed with the needs of the safety toxicologists in mind: 3D in vitro human liver models with high biological and physiological relevance, short turn-around times, capable of handling larger compound sets when needed, and high reproducibility decision-enabling datasets.

An icon demonstrating the market-leading 3D in vitro liver toxicology solutions by InSphero

Market-leading 3D in vitro biology you can rely on

The only 3D in vitro human liver model containing all liver cells, both parenchymal and non-parenchymal.
An icon showcasing the 3D in vitro liver safety platform trusted by pharmaceutical companies worldwide. 3D in vitro DILI testing used by the top ten pharmaceutical companies.

Trusted by pharmaceutical companies worldwide

Your team will value safety data backed by thousands of compound tests.
An icon demonstrating InSphero's 3D in vitro human liver model which enables fast and efficient safety assessment projects

Comprehensive 3D In Vitro Liver Toxicology platform for efficient and fast projects

From human DILI to mechanistic investigations, from cross-species testing to understanding clinical events.

Services & Products

Click to discover

Your Success is Our Mission

Schedule a consultation with our experts

Our Approach to 3D In Vitro Liver Toxicology

Reliable and fast hazard identification in 3D in vitro liver safety assessment

Reliable and fast hazard identification

With 3D InSightâ„¢ human liver models, potential drug-induced hepatotoxicity is identified based on 7/14-day treatment and viability readout.
Mechanism of action assessment for preclinical DILI

Mechanism of action assessment

Discover mitigation routes by understanding the mechanism of action of in vitro liver hepatotoxicity through transcriptomics and causality assays.

Cross-species 3D in vitro liver safety analysis

Cross-species events

Preemptively identify safety hazards in different species to accelerate your pre-clinical process.

Services

3D InSightâ„¢ Predictive Toxicology Service | 3D In Vitro DILI Testing
3D InSightâ„¢ Investigative Liver Safety Services | 3D In Vitro Liver Safety Services

Products

3D InSightâ„¢ Human Liver Microtissues
Akuraâ„¢ 3D SureKit
Scroll to Top

Your Success is Our Mission - Get in Touch

Fill in form below to contact our 3D in vitro experts

Sign up for our Newsletter

Get the latest news on 3D in vitro research

View resource

Fill in the form below to view this resource